Mito.newsMito.news
← All articlesEditorial brief · abstract-levelScore 90/100Confidence high
biorxiv2026-09-09mitophagyParkinson diseaseimportstructural biology

Vertebrate PINK1 needs TOM20 and its terminal extensions to keep the kinase domain folded

Human PINK1 has been a recombinant headache because vertebrates rewired how the kinase stays folded. Predicted TOM20 binding is mostly a vertebrate trick, coinciding with a rewritten N- and C-terminal extension interface. Insect PINK1 purifies active; vertebrate PINK1 does not, until you give it insect extensions or extra TOM20. A mostly human chimera then scores R152W as likely pathogenic.

Mito.news · at a glance

Signal profile (abstract-level)

mitophagy · Parkinson disease · import · structural biology

Score 90/100BIORXIVhigh confidencemitophagy
90
Importance
60
Mito signal
67
Dysfunction
75
Evidence
30
Translational

Editorial signal profile from the abstract (importance score, mito keywords, dysfunction tags, evidence density, translational cues). Not a figure reproduced from the preprint PDF.

Finding. Human PINK1 has refused to be a well-behaved recombinant kinase because vertebrates changed the folding rules. Shomali, Veyron and Trempe compare 48 metazoan PINK1s. Predicted binding to the import receptor TOM20 is mostly a vertebrate feature, and it arrives with a rewritten N- and C-terminal extension (NTE, CTE) interface. Beetle and other invertebrate PINK1s purify active. Vertebrate enzymes do not show ubiquitin kinase activity off the column. Humanize ten residues in the Tribolium NTE-CTE and NMR says the protein now binds human TOM20. Give recombinant human PINK1 extra TOM20 and activity rises. Build a chimera that is mostly human kinase on beetle extensions and you finally have catalysis, provided the extensions still talk to the C-lobe. That enzyme calls R152W likely pathogenic.

Why this paper matters

Early-onset Parkinson disease genetics pointed at PINK1 twenty years ago. Structural work then happened in insects because human protein died in the tube. This paper says that was not a technical nuisance. It was evolution. Vertebrate PINK1 appears to use the mitochondrial import machine as a folding chaperone, not only as a ticket into the organelle.

The chimera is the reagent the field can actually use: a human kinase domain that works, still propped by insect extensions. Variant interpretation (R152W) is the first obvious product. The conceptual product is bigger. If TOM20 occupancy keeps PINK1 folded, import stress is a PINK1-inactivation route.

How to read the score

Nineties. Core mitophagy kinase, Parkinson, a solvable recombinant problem, TOM20 as a fold factor. Confidence is high for the activity split and the chimera rules, a notch lower for “vertebrate PINK1 always needs TOM20 in vivo.”

Caveats

Not full-length human PINK1. Not a patient fibroblast folding study. Insect structures are still the pictures we have.

What to do with it

If you purify PINK1, switch to the chimera or add TOM20 before you declare a variant kinase-dead. If you model mitophagy, put NTE-CTE and TOM20 in the stability equation. Pull the ten-residue humanization and the R152W assay.

Free HTML is above. Bots pay for JSON at /api/v1/papers/10-64898-2026-09-05-749644. Optional wallet tester: MetaMask ($0.005).

Source preprint

Evolutionary analysis of PINK1 reveals key roles of the N- and C-terminal extensions and TOM20 in folding its kinase domain

10.64898/2026.09.05.749644

Shomali T, Veyron S, Trempe J.

Related briefs